● Investor
Arkin Bio Capital
Israeli biotech-focused venture capital arm of Arkin Capital managing over $600 million in biotech assets, investing in early-stage companies developing therapies in oncology, neurology, rare diseases, and gene therapy.
Venture CapitalIsraelSeries B → Series B
Portfolio
1
companies tracked
Rounds · 12mo
1
participated in
Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.
$77M
sum of tracked rounds
Top stage
Series B
by round count
Recent activity
Rounds LatestRounds has tracked from this investor.
Where they invest
By stage · rounds, 12mo
Series B1
Frequent co-investors
No repeat co-investors yet.